EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 35 / No 11 (Novembre 2019) Med Sci (Paris), 35 11 (2019) 891-895 References
Free Access
Issue
Med Sci (Paris)
Volume 35, Number 11, Novembre 2019
Page(s) 891 - 895
Section Forum
DOI https://doi.org/10.1051/medsci/2019173
Published online 17 December 2019
  1. Hall SS. Size matters: how height affects the health, happiness, and success of boys - and the men they become. New York : Houghton Mifflin Company ; 2006 : 388 p. [Google Scholar]
  2. Perelman J. Are chronic diseases related to height? Results from the Portuguese national health interview survey. Econ Hum Biol 2014 ; 15 : 56–66. [CrossRef] [PubMed] [Google Scholar]
  3. Magnusson PK, Gunnell D, Tynelius P, et al. Strong inverse association between height and suicide in a large cohort of Swedish men: evidence of early life origins of suicidal behavior? Am J Psychiatry 2005 ; 162 : 1373–5. [CrossRef] [PubMed] [Google Scholar]
  4. Feldman SD. The presentation of shortness in everyday life. Height and heightism in American society: toward a sociology of stature. In : Feldman SD, Thielbar GW, eds. Life styles: diversity in American society. Boston : Little Brown, 1975. 437–43. [Google Scholar]
  5. Herpin N. Le pouvoir des grands. Paris : La Découverte ; 2006 : 110 p. [Google Scholar]
  6. Lasco G Height matters: the making, meanings and materialities of human stature in the Philippines. Thèse doctorale. Amsterdam : University of Amsterdam, 2017. [Google Scholar]
  7. Wheeler PG, Bresnahan K, Shephard BA, et al.. Short stature and functional impairment. Arch Pediatr Adolesc Med 2004 ; 158 : 236–43. [Google Scholar]
  8. Case A, Paxson C. Stature and status: height, ability, and labor market outcomes. J Political Econ 2008 ; 116 : 499–532. [CrossRef] [Google Scholar]
  9. Manfredini M, Breschi M, Fornasin M, Seghieri C. Height, socioeconomic status and marriage in Italy around 1900. Eco Hum Biology 2013 ; 11 : 465–73. [CrossRef] [Google Scholar]
  10. Weiss G. The normal, the natural, and the normative: a Merleau-Pontian legacy to feminist theory, critical race theory, and disability studies. Continental Philosophy Review 2015 ; 48 : 77–93. [Google Scholar]
  11. Pyett P, Rayner J, Venn A, et al. Using hormone treatment to reduce the adult height of tall girls: are women satisfied with the decision in later years? Soc Sci Med 2005 ; 61 : 1629–39. [CrossRef] [PubMed] [Google Scholar]
  12. Rayner JA, Pyett P, Astbury J. The medicalization of ‘tall’ girls: a discourse analysis of medical literature on the use of synthetic oestrogen to reduce female height. Soc Sci Med 2010 ; 71 : 1076–83. [CrossRef] [PubMed] [Google Scholar]
  13. Agence américaine des produits alimentaires et médicamenteux (FDA). Briefing document. Endocrinologic and metabolic drugs advisory committee June 10, 2003 Humatrope® (somatropin [rDNA origin] for injection) for non-growth hormone deficient short stature. Vol. 1. https://wayback.archive-it.org/7993/20170405134939/https://www.fda.gov/ohrms/dockets/ac/03/briefing/3957B1_01_Lilly-Humatrope.pdf. [Google Scholar]
  14. Agence européenne des médicaments (AEM). EMEA/423515/2007 - Questions and answers on recommendation for the refusal of a change to the marketing authorisation for NutropinAq 2007. https://www.ema.europa.eu/documents/smop/questions-answers-recommendation-refusal-change-marketing-authorisation-nutropinaq_en.pdf. [Google Scholar]
  15. Xue T, Gao Y, Wang S, Wang P. An examination of the effects of different doses of recombinant human growth hormone on children with growth hormone deficiency. Exp Ther Medicine 2016 ; 11 : 1647–52. [CrossRef] [Google Scholar]
  16. Conrad P. Medicalization and social control. Ann Rev Sociology 1992 ; 18 : 209–32. [CrossRef] [Google Scholar]
  17. Brown P, Brandel JP, Sato T, et al. Emerging infectious iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 2012 ; 18 : 901–7. [CrossRef] [PubMed] [Google Scholar]
  18. Morrison M. Growth hormone, enhancement and the pharmaceuticalisation of short stature. Soc Sci Med 2015 ; 131 : 305–12. [CrossRef] [PubMed] [Google Scholar]
  19. Allen DB, Fost N. HGH for short stature: ethical issues raised by expanded access. J Pediatr 2004 ; 144 : 648–52. [CrossRef] [PubMed] [Google Scholar]
  20. Rosenbloom AL. Idiopathic short stature: conundrums of definition and treatment. International. J Pediat Endocrinol 2009 ; 2009 : 1–5. [Google Scholar]
  21. Hardin DS, Kemp SF, Allen DB. Twenty years of recombinant human growth hormone in children: relevance to pediatrics care providers. Clin Pediat 2007 ; 46 : 179–86. [CrossRef] [Google Scholar]
  22. Cohen P, Rogol AD, Deal CL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the growth hormone research society, the Lawson Wilkins pediatric endocrine society, and the European society for paediatric endocrinology workshop. J Clin Endocrinol Metab 2008 ; 93 : 4210–7. [CrossRef] [PubMed] [Google Scholar]
  23. Verweij M, Kortmann F. Moral assessment of growth hormone therapy for children with idiopathic short stature. J Med Ethics 1997 ; 23 : 305–9. [CrossRef] [PubMed] [Google Scholar]
  24. Visser-van Balen H, Sinnema G, Greenen R. Growing up with short stature: psychosocial development and hormone treatment: a critical review. Arch Dis Child 2006 ; 91 : 433–9. [CrossRef] [PubMed] [Google Scholar]
  25. Voss LD, Sandberg DE. The psychological burden of short stature: evidence against. Eur J Endocrinol 2004 ; 151 : 29–33. [Google Scholar]
  26. Sandel M. The case against perfection. Ethics in the age of genetic engineering. Harvard : Belknap Press ; 2007 : p. 176. [Google Scholar]
  27. Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr 2016 ; 86 : 361–97. [Google Scholar]
  28. Bateman S, Gayon J. L’amélioraiton humaine. Trois usages, trois enjeux. Med Sci (Paris) 2012 ; 28 : 887–91. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  29. M Gaille. Des mots et des maux. Que peut-on espérer des récits de vie dans la relation de soin à travers les âges ? Med Sci (Paris) 2012 ; 28 : 213–4. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  30. Oliver M, Barnes C. The new politics of disablement. London : Palgrave Macmillan ; 2012 : 252. [Google Scholar]
  31. Baron J, Sävendahl L, De Luca F, et al.. Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol 2015 ; 11 : 735–46. [CrossRef] [PubMed] [Google Scholar]
  32. Murano MC. Critical paediatric bioethics and the treatment of short stature. An interdisciplinary study. Linköping Studies in Arts and Sciences n° 764. Linköping, Sweden : Linköping University Electronic Press, 2019. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.